Dynamic distribution and expression in vivo of human endostatin gene delivered by adenoviral vector.
暂无分享,去创建一个
Wenlin Huang | Ran-yi Liu | Bi-jun Huang | Jiang-xue Wu | Jia-ling Huang | Guo-An He | Gang Xue | Zhi-hui Liang | Lin Xiao | Xia Xiao | Ben-Ling Xu
[1] Wenlin Huang,et al. Endostatin gene therapy for liver cancer by a recombinant adenovirus delivery. , 2004, World journal of gastroenterology.
[2] Tianyuan Zhang,et al. The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells. , 2004, Biochemical and biophysical research communications.
[3] J. Fernández-Piqueras,et al. Real-time PCR designs to estimate nuclear and mitochondrial DNA copy number in forensic and ancient DNA studies. , 2004, Forensic science international.
[4] K. Ihara,et al. Characteristic expression of aryl hydrocarbon receptor repressor gene in human tissues: organ-specific distribution and variable induction patterns in mononuclear cells. , 2004, Life sciences.
[5] Tianyuan Zhang,et al. Canstatin-N fragment inhibits in vitro endothelial cell proliferation and suppresses in vivo tumor growth. , 2003, Biochemical and biophysical research communications.
[6] S. J. Flint,et al. Unusual Properties of Adenovirus E2E Transcription by RNA Polymerase III , 2003, Journal of Virology.
[7] F. Bloom,et al. Quantitation of gene expression in neural precursors by reverse-transcription polymerase chain reaction using self-quenched, fluorogenic primers. , 2003, Analytical biochemistry.
[8] Zhidong Zhang,et al. Detection of all seven serotypes of foot-and-mouth disease virus by real-time, fluorogenic reverse transcription polymerase chain reaction assay. , 2002, Journal of virological methods.
[9] C. Kahn,et al. Tumstatin, an Endothelial Cell-Specific Inhibitor of Protein Synthesis , 2002, Science.
[10] R. Bookstein,et al. Evaluation of endostatin antiangiogenesis gene therapy in vitro and in vivo , 2001, Cancer Gene Therapy.
[11] S. Szala,et al. Intra‐tumoral administration of naked plasmid DNA encoding mouse endostatin inhibits renal carcinoma growth , 2001, International journal of cancer.
[12] R. Kalluri,et al. Two RGD-independent αvβ3 Integrin Binding Sites on Tumstatin Regulate Distinct Anti-tumor Properties* , 2000, The Journal of Biological Chemistry.
[13] R. Weichselbaum,et al. Anti-angiogenic cues from vascular basement membrane collagen. , 2000, Cancer research.
[14] S. Woo,et al. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[15] A. Feldman,et al. Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice. , 2000, Cancer research.
[16] R. Kalluri,et al. Canstatin, a Novel Matrix-derived Inhibitor of Angiogenesis and Tumor Growth* , 2000, The Journal of Biological Chemistry.
[17] R. Crystal. The body as a manufacturer of endostatin , 1999, Nature Biotechnology.
[18] J. Folkman. Antiangiogenic gene therapy. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[19] S. J. Flint,et al. The Tripartite Leader Sequence of Subgroup C Adenovirus Major Late mRNAs Can Increase the Efficiency of mRNA Export , 1998, Journal of Virology.
[20] Thomas Boehm,et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance , 1997, Nature.
[21] William Arbuthnot Sir Lane,et al. Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.
[22] J. Folkman,et al. Blood Vessel Formation: What Is Its Molecular Basis? , 1996, Cell.
[23] D. Hanahan,et al. Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.
[24] M. Mehtali,et al. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli , 1996, Journal of virology.
[25] Lars Holmgren,et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.
[26] J. Folkman. What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.
[27] J. Folkman,et al. Anti‐Angiogenesis: New Concept for Therapy of Solid Tumors , 1972, Annals of surgery.
[28] P. Okunieff,et al. Intratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in MCa-4 murine mammary carcinomas. , 2001, Cancer research.
[29] G. Cauet,et al. Adenovirus-mediated delivery of antiangiogenic genes as an antitumor approach , 2001, Cancer Gene Therapy.
[30] J. Folkman. Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.